En savoir plus
This book, by bringing together critical pharmaceutical studies and feminist technoscience studies, explores the way drugs produce sexed and/or gendered identities for those who take - or resist - them, and how feminist technoscience studies can contribute a theoretical lens with which to observe sex and gender in the pharmaceuticalization processes. Topics explored in this diverse collection include the use of hormones to delay puberty onset for trans children; HPV vaccination against cervical cancer in Sweden, the UK, Austria and Colombia; Alzheimer's discourses; and the medication of prostate issues. Ericka Johnson has brought together an innovative and timely collection that demonstrates gender as relevant in studies of pharmaceuticals, and provides multiple examples of methodological and theoretical tools to consider gender while studying drugs.
Table des matières
1. Introduction.- Part I. Making Scientific and Medical Truths.- 2. Alzheimer's in the Making.- 3. The Pharmaceuticalized Prostate.- 4. New Puberty; New Trans: Children, Pharmaceuticals and Politics.- Part II. Creating Subjectivities for "Patients" in Advertising.- 5. Prescribing Relational Subjectivities.- 6. You Will Protect Your Daughter, Right?.- Part III. Different HPV Vaccines.- 7. Evidence, Sex and State Paternalism.- 8. Young Women and the Pharmaceutical Burden of HPV Vaccinations.- 9. Two Shots for Children.- 10. Sexing Drugs, Refracting Discourses.
A propos de l'auteur
Ericka Johnson is Senior Lecturer and Assistant Director of Technology and Social Change at Linköping University, Sweden. Her research interests include medical bodies and subjects as refracted by medical technologies.
Résumé
This book, by bringing together critical pharmaceutical studies and feminist technoscience studies, explores the way drugs produce sexed and/or gendered identities for those who take – or resist – them, and how feminist technoscience studies can contribute a theoretical lens with which to observe sex and gender in the pharmaceuticalization processes. Topics explored in this diverse collection include the use of hormones to delay puberty onset for trans children; HPV vaccination against cervical cancer in Sweden, the UK, Austria and Colombia; Alzheimer’s discourses; and the medication of prostate issues. Ericka Johnson has brought together an innovative and timely collection that demonstrates gender as relevant in studies of pharmaceuticals, and provides multiple examples of methodological and theoretical tools to consider gender while studying drugs.
